A Clinical Trial of Omalizumab in Participants With Chronic Rhinosinusitus With Nasal Polyps

NCT03280537 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Nasal Polyps
Chronic Rhinosinusitis

Interventions

DRUG: Omalizumab
DRUG: Placebo

Sponsor

Hoffmann-La Roche